{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:34:14Z","timestamp":1788633254752,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T00:00:00Z","timestamp":1634083200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115583"],"award-info":[{"award-number":["115583"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["RIF14-0078"],"award-info":[{"award-number":["RIF14-0078"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018\u201305501"],"award-info":[{"award-number":["2018\u201305501"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201700040I\/HHSN27200001"],"award-info":[{"award-number":["HHSN272201700040I\/HHSN27200001"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008013","name":"University of Texas Medical Branch at Galveston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006447","name":"Universit\u00e4t Z\u00fcrich","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009252","name":"Science for Life Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009252","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ebiom.2021.103652","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T06:45:09Z","timestamp":1635835509000},"page":"103652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis"],"prefix":"10.1016","volume":"73","author":[{"given":"Katja","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Erlandsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven-Kevin","family":"Hotop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Kuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6410-5755","authenticated-orcid":false,"given":"Jon","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Haldimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveiga","family":"Grinberga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Berruga-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Huseby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shariatgorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Lindmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Platzack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik C.","family":"B\u00f6ttger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2979-679X","authenticated-orcid":false,"given":"Lena E.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Vingsbo Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7456-9182","authenticated-orcid":false,"given":"Diarmaid","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Br\u00f6nstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4062-7743","authenticated-orcid":false,"given":"Per E.","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgars","family":"Liepinsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-0384","authenticated-orcid":false,"given":"Sven N.","family":"Hobbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ebiom.2021.103652_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103652_bib0002","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41585-018-0106-x","article-title":"Nonantibiotic prevention and management of recurrent urinary tract infection","volume":"15","author":"Sihra","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"13","key":"10.1016\/j.ebiom.2021.103652_bib0003","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103652_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41579-020-0324-0","article-title":"Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies","volume":"18","author":"Klein","year":"2020","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103652_bib0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1080\/00325481.2017.1246055","article-title":"An update on the management of urinary tract infections in the era of antimicrobial resistance","volume":"129","author":"Bader","year":"2017","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103652_bib0006","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.eimc.2016.11.005","article-title":"Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)","volume":"35","author":"de Cueto","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.ebiom.2021.103652_bib0007","doi-asserted-by":"crossref","first-page":"w20110","DOI":"10.4414\/smw.2019.20110","volume":"149","author":"Zanichelli","year":"2019","journal-title":"Swiss Med Wkly"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103652_bib0008","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jac\/dkr081","article-title":"Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)","volume":"66","author":"Castanheira","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103652_bib0009","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","article-title":"Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents","volume":"132","author":"Bader","year":"2020","journal-title":"Postgrad Med"},{"issue":"5","key":"10.1016\/j.ebiom.2021.103652_bib0010","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3109\/15376516.2015.1026008","article-title":"Ciprofloxacin-induced neurotoxicity: evaluation of possible underlying mechanisms","volume":"25","author":"Ilgin","year":"2015","journal-title":"Toxicol Mech Methods"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103652_bib0011","doi-asserted-by":"crossref","first-page":"e02165","DOI":"10.1128\/AAC.02165-18","article-title":"A systematic review of single-dose aminoglycoside therapy for urinary tract infection: is it time to resurrect an old strategy?","volume":"63","author":"Goodlet","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103652_bib0012","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/133.1.14","article-title":"Inhibition of the antibacterial activity of gentamicin by urine","volume":"133","author":"Minuth","year":"1976","journal-title":"J Infect Dis"},{"issue":"5-6","key":"10.1016\/j.ebiom.2021.103652_bib0013","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000342423","article-title":"Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine","volume":"90","author":"Burian","year":"2012","journal-title":"Pharmacology"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103652_bib0014","doi-asserted-by":"crossref","first-page":"731.e1","DOI":"10.1016\/j.urology.2014.04.048","article-title":"The influence of urinary pH on antibiotic efficacy against bacterial uropathogens","volume":"84","author":"Yang","year":"2014","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.ebiom.2021.103652_bib0015","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1128\/AAC.00602-16","article-title":"Urinary tract physiological conditions promote Ciprofloxacin resistance in low-level-quinolone-resistant Escherichia coli","volume":"60","author":"Mart\u00edn-Guti\u00e9rrez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103652_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jmii.2019.08.002","article-title":"Association between urine pH and common uropathogens in children with urinary tract infections","volume":"54","author":"Lai","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103652_bib0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103652_bib0018","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1093\/jac\/dky546","article-title":"In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"74","author":"Juhas","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103652_bib0019","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside Resistance: The Emergence of Acquired 16S Ribosomal RNA Methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103652_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/cid\/ciz640","article-title":"Plazomicin: A New Aminoglycoside","volume":"70","author":"Saravolatz","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103652_bib0021","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/d41573-021-00074-y","article-title":"ENABLE: an engine for European antibacterial drug discovery and development","volume":"20","author":"Olliver","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ebiom.2021.103652_bib0022","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3389\/fmicb.2017.02275","article-title":"In vitro activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-resistant Enterobacteriaceae clinical strains","volume":"8","author":"Hu","year":"2017","journal-title":"Front Microbiol."},{"issue":"2","key":"10.1016\/j.ebiom.2021.103652_bib0023","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2017.03.006","article-title":"Invitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"88","author":"Kang","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103652_bib0024","doi-asserted-by":"crossref","first-page":"e02585","DOI":"10.1128\/AAC.02585-17","article-title":"Efficacy of Apramycin against multidrug-resistant Acinetobacter baumannii in the Murine Neutropenic Thigh Model","volume":"62","author":"Kang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103652_bib0025","doi-asserted-by":"crossref","first-page":"e01374","DOI":"10.1128\/AAC.01374-19","article-title":"Synergistic combinations and repurposed antibiotics active against the pandrug-resistant Klebsiella pneumoniae Nevada Strain","volume":"63","author":"Brennan-Krohn","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103652_bib0026","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.cmi.2020.12.004","article-title":"Efficacy of EBL-1003 (apramycin) against Acinetobacter baumannii lung infections in mice","volume":"27","author":"Becker","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103652_bib0027","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1089\/mdr.2019.0075","article-title":"Dissemination of International Clone II","volume":"26","author":"Nafplioti","year":"2020","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ebiom.2021.103652_bib0028","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fmicb.2020.00425","article-title":"Activity of Apramycin against carbapenem-resistant and Hypervirulent","volume":"11","author":"Hao","year":"2020","journal-title":"Front Microbiol."},{"issue":"17","key":"10.1016\/j.ebiom.2021.103652_bib0029","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.3390\/ijms21176133","article-title":"Epidemiologic, phenotypic, and structural characterization of Aminoglycoside-resistance Gene aac(3)-IV","volume":"21","author":"Plattner","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103652_bib0030","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.analchem.8b03586","article-title":"Subcellular quantification of Uptake in gram-negative bacteria","volume":"91","author":"Prochnow","year":"2019","journal-title":"Anal Chem"},{"issue":"4","key":"10.1016\/j.ebiom.2021.103652_bib0031","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/cpt.2104","article-title":"Model-informed drug development for antimicrobials: translational PK and PK\/PD Modeling to predict an efficacious human dose for apramycin","volume":"109","author":"Sou","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2021.103652_bib0032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103652_bib0033","doi-asserted-by":"crossref","first-page":"e01650","DOI":"10.1128\/AAC.01650-19","article-title":"Renal glycosuria as a novel early sign of colistin-induced kidney damage in mice","volume":"63","author":"Samodelov","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103652_bib0034","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.23.6.835","article-title":"Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin","volume":"23","author":"Bryan","year":"1983","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ebiom.2021.103652_bib0035","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/jb.157.3.863-867.1984","article-title":"Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus","volume":"157","author":"Eisenberg","year":"1984","journal-title":"J Bacteriol"},{"issue":"12","key":"10.1016\/j.ebiom.2021.103652_bib0036","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/mrc.1270111210","article-title":"Determination of pKa values using 15N and 13C nuclear magnetic resonance spectroscopy. The case of apramycin","volume":"11","author":"Paschal","year":"1978","journal-title":"Organ Magn Reson"},{"issue":"9","key":"10.1016\/j.ebiom.2021.103652_bib0037","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/bi9626822","article-title":"Biologically important conformations of aminoglycoside antibiotics bound to an aminoglycoside 3\u2032-phosphotransferase as determined by transferred nuclear Overhauser effect spectroscopy","volume":"36","author":"Cox","year":"1997","journal-title":"Biochemistry"},{"issue":"24","key":"10.1016\/j.ebiom.2021.103652_bib0038","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.carres.2003.08.005","article-title":"An isocratic separation of underivatized gentamicin components, 1H NMR assignment and protonation pattern","volume":"338","author":"Lesniak","year":"2003","journal-title":"Carbohydr Res"},{"issue":"33","key":"10.1016\/j.ebiom.2021.103652_bib0039","doi-asserted-by":"crossref","first-page":"21094","DOI":"10.1021\/acsomega.0c02744","article-title":"Individual pK a Values of Tobramycin, Kanamycin B, Amikacin, Sisomicin, and Netilmicin determined by multinuclear NMR Spectroscopy","volume":"5","author":"Alkhzem","year":"2020","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.ebiom.2021.103652_bib0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/ALN.0b013e3181ca361f","article-title":"Hypercapnia and acidosis in sepsis: a double-edged sword?","volume":"112","author":"Curley","year":"2010","journal-title":"Anesthesiology"},{"issue":"11","key":"10.1016\/j.ebiom.2021.103652_bib0041","first-page":"e11514","article-title":"Linezolid induced lactic acidosis: the side effect, clinician should be aware of","volume":"12","author":"Nightingale","year":"2020","journal-title":"Cureus."},{"issue":"7","key":"10.1016\/j.ebiom.2021.103652_bib0042","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/CCM.0b013e31817d1b59","article-title":"Sustained hypercapnic acidosis during pulmonary infection increases bacterial load and worsens lung injury","volume":"36","author":"O'Croinin","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2021.103652_bib0043","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ejcb.2018.06.001","article-title":"Extracellular pH and lung infections in cystic fibrosis","volume":"97","author":"Massip-Copiz","year":"2018","journal-title":"Eur J Cell Biol"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396421004461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:15:36Z","timestamp":1762456536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396421004461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"alternative-id":["S2352396421004461"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103652","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial activity of apramycin at acidic pH warrants wide therapeutic window in the treatment of complicated urinary tract infections and acute pyelonephritis","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2021.103652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103652"}}